ストックスクリーナーアプリを入手
0.8249
2.59%
-0.0219
前日終値:
$0.8468
開ける：
$0.88
24時間の取引高:
589.37K
Relative Volume:
0.54
時価総額：
$130.93M
収益：
-
当期純損益:
$-41.23M
株価収益率:
-1.1784
EPS:
-0.7
ネットキャッシュフロー:
$-11.54M
1週間 パフォーマンス:
+1.98%
1か月 パフォーマンス:
+15.39%
6か月 パフォーマンス:
+26.93%
1年 パフォーマンス:
-61.09%
1日の値動き範囲:
$0.8018
$0.8849
1週間の範囲:
$0.794
$0.89
52週間の値動き範囲:
$0.395
$3.38
Renovaro Inc Stock (RENB) Company Profile
名前
Renovaro Inc
セクター
電話
45 39179840
住所
CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES
RENB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RENB
Renovaro Inc
|
0.8249 | 130.93M | 0 | -41.23M | -11.54M | -0.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Renovaro Inc (RENB) 最新ニュース
Renovaro (NASDAQ:RENB) Posts Earnings Results - MarketBeat
Investors Eye Biotech Sector as Cancer Therapy Market Surges - KamloopsBCNow
Renovaro: Fiscal Q2 Earnings Snapshot - CTPost
Renovaro: Fiscal Q2 Earnings Snapshot -February 19, 2025 at 05:03 pm EST - Marketscreener.com
RENOVARO INC. SEC 10-Q Report - TradingView
Some Of Renovaro's Financial Statements Contain Material Misstatements, SEC Filing Shows - Marketscreener.com
This AI Stock Is Up 50% in 2025. Is It Too Late to Buy? - The Globe and Mail
SG Americas Securities LLC Boosts Stake in Renovaro Inc. (NASDAQ:RENB) - Defense World
Renovaro (NASDAQ:RENB) Stock Quotes, Forecast and News Summary - Benzinga
AMC Networks (AMCX) To Report Earnings Tomorrow: Here Is What To Expect - The Globe and Mail
Renovaro Biosciences Updates CEO Compensation Plan - TipRanks
Renovaro Inc (RENB)’s Market Momentum: Closing Strong at 0.70, Up 4.32 - The Dwinnex
RENB (Renovaro Inc) may reap gains as insiders became active recently - Knox Daily
After Falling -6.53% During The Past Week, Should You Still Buy Renovaro Inc (NASDAQ: RENB)? - Marketing Sentinel
Sagimet Biosciences Inc (NASDAQ:SGMT) Up 47.7% Since 52-Week Low; YTD Rose 1.56% – Here’s What You Need To Do – Marketing Sentinel - Marketing Sentinel
Renovaro Inc (RENB) Stock: From Low to High in 52 Weeks - The InvestChronicle
Renovaro Inc. (NASDAQ:RENB) Stock Holdings Increased by JPMorgan Chase & Co. - Defense World
Quarterly Snapshot: Quick and Current Ratios for Renovaro Inc (RENB) - The Dwinnex
Renovaro Inc (RENB)’s results reveal risk - US Post News
Barclays PLC Has $34,000 Stock Position in Renovaro Inc. (NASDAQ:RENB) - Defense World
Short Interest in Renovaro Inc. (NASDAQ:RENB) Rises By 30.7% - MarketBeat
Renovaro Inc. appoints new CFO Nathen Fuentes - Investing.com India
Renovaro Inc. appoints new CFO Nathen Fuentes By Investing.com - Investing.com South Africa
Geode Capital Management LLC Decreases Stake in Renovaro Inc. (NASDAQ:RENB) - Defense World
Renovaro To Buy Predictive Oncology in All-Stock Deal - Pulse 2.0
Renovaro Biosciences Subsidiary Appoints New CEO - MSN
Renovaro appoints Nathen Fuentes as finance chief - MSN
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Predictive Oncology Inc.POAI - The Malaysian Reserve
Renovaro Biosciences Merges with Predictive Oncology - MSN
PREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc.POAI - Marketscreener.com
Renovaro Inc. appoints new CEO for subsidiary By Investing.com - Investing.com Australia
Nathen Fuentes Joins Renovaro as Chief Financial Officer - citybiz
Renovaro BioSciences issues shareholder letter, provides corporate update - TipRanks
Renovaro Taps Nathen Fuentes as Finance Chief - MarketWatch
Renovaro Issues Shareholder Letter and Provides Corporate Update - The Manila Times
Renovaro Inc. appoints new CEO for subsidiary - Investing.com
Renovaro To Buy Predictive Oncology In All-Stock Deal - Pulse 2.0
Predictive Oncology shares rise 71% as takeover by Renovaro is announced - Mugglehead
Renovaro to Acquire Predictive Oncology - citybiz
M&A: Predictive Oncology to be Acquired by Renovaro - HIT Consultant
POAI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Predictive Oncology Inc. Is Fair to Shareholders - Business Wire
Renovaro to acquire Predictive Oncology in all-stock transaction - TipRanks
Renovaro to Acquire Predictive Oncology in All-Stock Transaction - The Manila Times
Predictive Oncology in Deal to Be Sold to Renovaro - MarketWatch
Renovaro to Acquire Predictive Oncology in All-Stock Transaction - Benzinga
Predictive Oncology Announces Agreement to be Acquired by Renovaro - GlobeNewswire
Renovaro Inc (RENB) 財務データ
収益
当期純利益
現金流量
EPS
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):